Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway

Axel Dignass, Kathryn Lynch-Devaney, Heather Kindon, Lars Thim, Daniel K. Podolsky

Research output: Contribution to journalArticle

377 Citations (Scopus)

Abstract

The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or non-transformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGFβ bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-β and was not affected by the presence of immunoneutralizing anti-TGFβ antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.

Original languageEnglish (US)
Pages (from-to)376-383
Number of pages8
JournalJournal of Clinical Investigation
Volume94
Issue number1
StatePublished - Jul 1994

Fingerprint

Transforming Growth Factors
Glycoproteins
Mucins
Gastrointestinal Tract
Epithelial Cells
Cell Line
Peptides
Goblet Cells
Wounds and Injuries
Trefoil Factors
Colonic Neoplasms
Small Intestine
Immune Sera
Intercellular Signaling Peptides and Proteins
Colon
Peptide Hydrolases
Epithelium
Fibroblasts
Cytokines

Keywords

  • goblet cells
  • growth
  • healing
  • mucosal injury

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. / Dignass, Axel; Lynch-Devaney, Kathryn; Kindon, Heather; Thim, Lars; Podolsky, Daniel K.

In: Journal of Clinical Investigation, Vol. 94, No. 1, 07.1994, p. 376-383.

Research output: Contribution to journalArticle

Dignass, Axel ; Lynch-Devaney, Kathryn ; Kindon, Heather ; Thim, Lars ; Podolsky, Daniel K. / Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. In: Journal of Clinical Investigation. 1994 ; Vol. 94, No. 1. pp. 376-383.
@article{3b0b0a25af124b169aedbe3cc4206ef2,
title = "Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway",
abstract = "The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or non-transformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGFβ bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-β and was not affected by the presence of immunoneutralizing anti-TGFβ antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.",
keywords = "goblet cells, growth, healing, mucosal injury",
author = "Axel Dignass and Kathryn Lynch-Devaney and Heather Kindon and Lars Thim and Podolsky, {Daniel K.}",
year = "1994",
month = "7",
language = "English (US)",
volume = "94",
pages = "376--383",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway

AU - Dignass, Axel

AU - Lynch-Devaney, Kathryn

AU - Kindon, Heather

AU - Thim, Lars

AU - Podolsky, Daniel K.

PY - 1994/7

Y1 - 1994/7

N2 - The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or non-transformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGFβ bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-β and was not affected by the presence of immunoneutralizing anti-TGFβ antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.

AB - The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or non-transformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGFβ bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-β and was not affected by the presence of immunoneutralizing anti-TGFβ antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.

KW - goblet cells

KW - growth

KW - healing

KW - mucosal injury

UR - http://www.scopus.com/inward/record.url?scp=0028360991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028360991&partnerID=8YFLogxK

M3 - Article

C2 - 8040278

AN - SCOPUS:0028360991

VL - 94

SP - 376

EP - 383

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -